author-photo

M. Main

Great Ormond Street Hospital
Hammersmith Hospital
UCL Institute of Child Health

100

Papers

2860

Citations

Citation Trend

Filter By

Papers (99) Sort By

Journal Conference Others

Revised upper limb module for spinal muscular atrophy: 12 month changes: 12 month changes on RULM for SMA

2019 Muscle & Nerve
Show All
- Source
- Cite
- Save
Citations (33)
CMT AND NEUROPATHY

2019 Neuromuscular Disorders
Show All
- Source
- Cite
- Save
Citations (0)
Clinical features of facioscapulohumeral muscular dystrophy 1 in childhood

2019 Developmental Medicine & Child Neurology
Show All
- Source
- Cite
- Save
Citations (5)
Ambulatory function in spinal muscular atrophy : Age-related patterns of progression

2018 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (35)
The use of nusinersen in the “real world”: the UK and Ireland experience with the expanded access program (EAP)

2018 Neuromuscular Disorders
Show All
- Source
- Cite
- Save
Citations (2)
Revised Hammersmith Scale

2018
Show All
- Source
- Cite
- Save
Citations (0)
G299 Nusinersen (spinraza) is the first drug approved for spinal muscular atrophy (sma): initial experience in patients with sma type 1 treated in the expanded access program (eap)

2018 Archives of Disease in Childhood
Show All
- Source
- Cite
- Save
Citations (5)
Quantitative Evaluation of Lower Extremity Joint Contractures in Spinal Muscular Atrophy: Implications for Motor Function.

2018 Pediatric Physical Therapy
Show All
- Source
- Cite
- Save
Citations (9)
Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics

2017 Neuromuscular Disorders
Show All
- Source
- Cite
- Save
Citations (204)
Additional file 1: of Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy

2017
Show All
- Source
- Cite
- Save
Citations (0)